☆ 4.2 Article

Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)

Get Full Text
Add to Collection

Journal

JOURNAL OF INFECTION AND CHEMOTHERAPY
Volume 19, Issue 3, Pages 365-380

Publisher

ELSEVIER
DOI: 10.1007/s10156-013-0599-4

Keywords

Guideline; Vancomycin; Therapeutic drug monitoring; MRSA

Categories

Infectious Diseases Pharmacology & Pharmacy

Funding

  1. Pfizer Japan Inc.
  2. Astellas Pharma
  3. Shionogi Co., Ltd.
  4. MSD KK
  5. Taisho Toyama Pharmaceutical Co., Ltd.
  6. Takeda Pharmaceutical Company Limited
  7. Dainippon Sumitomo Pharma
  8. Grants-in-Aid for Scientific Research [23591485, 23390037] Funding Source: KAKEN

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.